dr. jurcic on lintuzumab and low-dose cytarabine for aml
Published 9 years ago • 256 plays • Length 2:06Download video MP4
Download video MP3
Similar videos
-
2:06
dr. jurcic on lintuzumab and low-dose cytarabine for aml
-
2:18
lintuzumab-ac225 combined with venetoclax for r/r aml: early results
-
1:41
dr. jurcic on the next steps for radioimmunotherapy
-
2:38
venetoclax in combination with low-dose cytarabine – a promising regimen for the treatment of aml
-
5:59
liposomal daunorubicin & cytarabine for aml
-
4:49
for older aml patients, venetoclax with low-dose cytarabine is safe and “promising”
-
5:39
venetoclax plus low-dose cytarabine in untreated older aml patients
-
1:32
is venetoclax in combination with low-dose cytarabine a safe regimen for the treatment of aml?
-
2:30
is low-dose cytarabine being overlooked in combination therapies for elderly aml?
-
4:13
ven-a-qui: low-dose cytarabine or azacitidine venetoclax and quizartinib in older patients with aml
-
5:13
vosaroxin/cytarabine in aml
-
1:29
dr. steensma on midostaurin for patients with aml
-
1:48
a new era for elderly aml patients
-
2:06
onvansertib with cytarabine or decitabine for r/r aml
-
1:43
dr. visani on tosedostat and cytarbine in elderly patients with aml
-
0:53
daunorubicin and cytarabine approved for aml treatment within nhs scotland
-
5:22
determining the optimal dose of induction therapy for patients with aml
-
5:30
treating acute myeloid leukemia with valor – vosaroxin in combination with cytarabine
-
10:54
gilteritinib for flt3-mutant aml